Iran (Islamic Republic of)

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
1.53 (1.34 - 1.71) 2019 Modelled IHME
1.6 (1.39 - 1.79) 2018 Modelled IHME
1.64 (1.42 - 1.82) 2017 Modelled IHME
1.63 (1.44 - 1.81) 2016 Modelled IHME
1.63 (1.44 - 1.81) 2015 Modelled IHME
1.64 (1.46 - 1.83) 2014 Modelled IHME
1.68 (1.49 - 1.87) 2013 Modelled IHME
1.73 (1.52 - 1.93) 2012 Modelled IHME
1.78 (1.57 - 2) 2011 Modelled IHME
1.83 (1.60 - 2.06) 2010 Modelled IHME
1.87 (1.64 - 2.10) 2009 Modelled IHME
1.91 (1.68 - 2.15) 2008 Modelled IHME
1.96 (1.72 - 2.20) 2007 Modelled IHME
2 (1.76 - 2.24) 2006 Modelled IHME
2.04 (1.79 - 2.29) 2005 Modelled IHME
2.08 (1.83 - 2.34) 2004 Modelled IHME
2.12 (1.86 - 2.39) 2003 Modelled IHME
2.16 (1.89 - 2.44) 2002 Modelled IHME
2.2 (1.92 - 2.48) 2001 Modelled IHME
2.23 (1.95 - 2.53) 2000 Modelled IHME
2.28 (1.99 - 2.59) 1999 Modelled IHME
2.32 (2.02 - 2.64) 1998 Modelled IHME
2.36 (2.05 - 2.69) 1997 Modelled IHME
2.4 (2.08 - 2.73) 1996 Modelled IHME
2.43 (2.11 - 2.77) 1995 Modelled IHME
2.45 (2.13 - 2.80) 1994 Modelled IHME
2.48 (2.14 - 2.82) 1993 Modelled IHME
2.5 (2.16 - 2.86) 1992 Modelled IHME
2.51 (2.18 - 2.89) 1991 Modelled IHME
2.52 (2.18 - 2.91) 1990 Modelled IHME
0.15 (0.11 - 0.19) 2015 Modelled WHO
1.7 (1.60 - 1.90) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.09 (0.07 - 0.11) 2019 Modelled IHME
0.09 (0.07 - 0.11) 2018 Modelled IHME
0.09 (0.07 - 0.11) 2017 Modelled IHME
0.09 (0.07 - 0.11) 2016 Modelled IHME
0.1 (0.08 - 0.12) 2015 Modelled IHME
0.1 (0.08 - 0.12) 2014 Modelled IHME
0.1 (0.08 - 0.12) 2013 Modelled IHME
0.1 (0.08 - 0.12) 2012 Modelled IHME
0.11 (0.09 - 0.13) 2011 Modelled IHME
0.11 (0.09 - 0.13) 2010 Modelled IHME
0.11 (0.09 - 0.14) 2009 Modelled IHME
0.12 (0.10 - 0.15) 2008 Modelled IHME
0.13 (0.11 - 0.16) 2007 Modelled IHME
0.14 (0.11 - 0.17) 2006 Modelled IHME
0.15 (0.12 - 0.18) 2005 Modelled IHME
0.15 (0.12 - 0.18) 2004 Modelled IHME
0.16 (0.13 - 0.19) 2003 Modelled IHME
0.16 (0.13 - 0.20) 2002 Modelled IHME
0.17 (0.14 - 0.21) 2001 Modelled IHME
0.18 (0.14 - 0.22) 2000 Modelled IHME
0.21 (0.17 - 0.26) 1999 Modelled IHME
0.29 (0.23 - 0.35) 1998 Modelled IHME
0.38 (0.31 - 0.47) 1997 Modelled IHME
0.5 (0.40 - 0.61) 1996 Modelled IHME
0.62 (0.50 - 0.76) 1995 Modelled IHME
0.76 (0.62 - 0.93) 1994 Modelled IHME
0.94 (0.75 - 1.14) 1993 Modelled IHME
1.14 (0.91 - 1.39) 1992 Modelled IHME
1.37 (1.09 - 1.67) 1991 Modelled IHME
1.61 (1.29 - 1.97) 1990 Modelled IHME
0.02 (0.01 - 0.03) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
1,477,370 (1,277,500 - 1,703,470) 1990 Modelled IHME
1,480,590 (1,282,460 - 1,701,730) 1991 Modelled IHME
1,466,860 (1,271,630 - 1,683,250) 1992 Modelled IHME
1,469,980 (1,273,350 - 1,674,250) 1993 Modelled IHME
1,481,560 (1,288,590 - 1,690,250) 1994 Modelled IHME
1,491,700 (1,297,380 - 1,703,280) 1995 Modelled IHME
1,499,510 (1,300,640 - 1,708,600) 1996 Modelled IHME
1,504,330 (1,305,980 - 1,711,980) 1997 Modelled IHME
1,507,440 (1,312,250 - 1,715,530) 1998 Modelled IHME
1,507,590 (1,315,560 - 1,714,170) 1999 Modelled IHME
1,504,040 (1,315,250 - 1,705,240) 2000 Modelled IHME
1,497,510 (1,312,260 - 1,694,570) 2001 Modelled IHME
1,492,090 (1,309,360 - 1,688,450) 2002 Modelled IHME
1,488,470 (1,307,650 - 1,678,600) 2003 Modelled IHME
1,480,700 (1,302,090 - 1,667,130) 2004 Modelled IHME
1,469,770 (1,293,130 - 1,650,570) 2005 Modelled IHME
1,458,230 (1,282,540 - 1,635,600) 2006 Modelled IHME
1,446,420 (1,270,710 - 1,622,400) 2007 Modelled IHME
1,434,060 (1,257,450 - 1,607,630) 2008 Modelled IHME
1,419,090 (1,243,770 - 1,591,030) 2009 Modelled IHME
1,402,150 (1,228,280 - 1,575,280) 2010 Modelled IHME
1,380,630 (1,212,720 - 1,545,660) 2011 Modelled IHME
1,355,140 (1,192,330 - 1,512,880) 2012 Modelled IHME
1,332,170 (1,178,020 - 1,484,890) 2013 Modelled IHME
1,317,970 (1,170,440 - 1,466,480) 2014 Modelled IHME
1,320,420 (1,166,950 - 1,469,020) 2015 Modelled IHME
1,336,550 (1,175,500 - 1,482,630) 2016 Modelled IHME
1,352,440 (1,176,480 - 1,507,390) 2017 Modelled IHME
1,339,460 (1,164,720 - 1,492,200) 2018 Modelled IHME
1,293,010 (1,130,790 - 1,439,190) 2019 Modelled IHME
1,400,000 (1,313,000 - 1,398,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.93 (2.63 - 3.29) 2019 Modelled IHME
2.9 (2.60 - 3.21) 2018 Modelled IHME
2.87 (2.60 - 3.19) 2017 Modelled IHME
2.83 (2.56 - 3.12) 2016 Modelled IHME
2.79 (2.54 - 3.07) 2015 Modelled IHME
2.71 (2.48 - 2.98) 2014 Modelled IHME
2.63 (2.39 - 2.88) 2013 Modelled IHME
2.55 (2.31 - 2.81) 2012 Modelled IHME
2.48 (2.24 - 2.72) 2011 Modelled IHME
2.4 (2.19 - 2.64) 2010 Modelled IHME
2.39 (2.18 - 2.63) 2009 Modelled IHME
2.42 (2.21 - 2.66) 2008 Modelled IHME
2.47 (2.26 - 2.71) 2007 Modelled IHME
2.53 (2.31 - 2.79) 2006 Modelled IHME
2.6 (2.37 - 2.88) 2005 Modelled IHME
2.7 (2.46 - 3.01) 2004 Modelled IHME
2.88 (2.61 - 3.22) 2003 Modelled IHME
3.08 (2.78 - 3.45) 2002 Modelled IHME
3.21 (2.89 - 3.64) 2001 Modelled IHME
3.22 (2.88 - 3.68) 2000 Modelled IHME
3.22 (2.83 - 3.70) 1999 Modelled IHME
3.22 (2.83 - 3.71) 1998 Modelled IHME
3.22 (2.82 - 3.72) 1997 Modelled IHME
3.23 (2.83 - 3.72) 1996 Modelled IHME
3.25 (2.84 - 3.75) 1995 Modelled IHME
3.27 (2.83 - 3.77) 1994 Modelled IHME
3.3 (2.86 - 3.81) 1993 Modelled IHME
3.35 (2.91 - 3.89) 1992 Modelled IHME
3.34 (2.86 - 3.86) 1991 Modelled IHME
3.38 (2.85 - 3.94) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
2,471 (2,220 - 2,773) 2019 Modelled IHME
2,419 (2,172 - 2,684) 2018 Modelled IHME
2,375 (2,146 - 2,641) 2017 Modelled IHME
2,317 (2,096 - 2,556) 2016 Modelled IHME
2,263 (2,059 - 2,488) 2015 Modelled IHME
2,175 (1,987 - 2,389) 2014 Modelled IHME
2,085 (1,896 - 2,285) 2013 Modelled IHME
1,996 (1,805 - 2,201) 2012 Modelled IHME
1,916 (1,735 - 2,105) 2011 Modelled IHME
1,839 (1,677 - 2,020) 2010 Modelled IHME
1,808 (1,654 - 1,994) 2009 Modelled IHME
1,816 (1,656 - 1,996) 2008 Modelled IHME
1,825 (1,672 - 2,004) 2007 Modelled IHME
1,849 (1,687 - 2,038) 2006 Modelled IHME
1,870 (1,708 - 2,072) 2005 Modelled IHME
1,924 (1,749 - 2,141) 2004 Modelled IHME
2,026 (1,835 - 2,260) 2003 Modelled IHME
2,131 (1,923 - 2,386) 2002 Modelled IHME
2,188 (1,970 - 2,483) 2001 Modelled IHME
2,169 (1,937 - 2,476) 2000 Modelled IHME
2,133 (1,878 - 2,450) 1999 Modelled IHME
2,096 (1,841 - 2,409) 1998 Modelled IHME
2,051 (1,796 - 2,373) 1997 Modelled IHME
2,023 (1,768 - 2,325) 1996 Modelled IHME
1,999 (1,744 - 2,305) 1995 Modelled IHME
1,973 (1,711 - 2,280) 1994 Modelled IHME
1,957 (1,696 - 2,260) 1993 Modelled IHME
1,967 (1,710 - 2,288) 1992 Modelled IHME
1,969 (1,687 - 2,273) 1991 Modelled IHME
1,976 (1,670 - 2,304) 1990 Modelled IHME
3,684 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
39 (35 - 43) 2019 Modelled IHME
39 (35 - 43) 2018 Modelled IHME
39 (35 - 43) 2017 Modelled IHME
39 (35 - 43) 2016 Modelled IHME
39 (35 - 44) 2015 Modelled IHME
39 (35 - 44) 2014 Modelled IHME
39 (35 - 44) 2013 Modelled IHME
39 (35 - 44) 2012 Modelled IHME
39 (35 - 44) 2011 Modelled IHME
39 (35 - 44) 2010 Modelled IHME
40 (35 - 44) 2009 Modelled IHME
40 (35 - 44) 2008 Modelled IHME
40 (36 - 45) 2007 Modelled IHME
40 (36 - 45) 2006 Modelled IHME
41 (36 - 45) 2005 Modelled IHME
41 (36 - 46) 2004 Modelled IHME
41 (37 - 46) 2003 Modelled IHME
42 (37 - 47) 2002 Modelled IHME
42 (37 - 47) 2001 Modelled IHME
42 (38 - 47) 2000 Modelled IHME
42 (37 - 47) 1999 Modelled IHME
42 (37 - 47) 1998 Modelled IHME
42 (37 - 47) 1997 Modelled IHME
42 (37 - 47) 1996 Modelled IHME
42 (37 - 47) 1995 Modelled IHME
42 (37 - 47) 1994 Modelled IHME
42 (37 - 47) 1993 Modelled IHME
42 (37 - 48) 1992 Modelled IHME
42 (37 - 48) 1991 Modelled IHME
43 (37 - 48) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
95 2018 Survey/reported WHO/UNICEF
95 2017 Survey/reported WHO/UNICEF
95 2016 Survey/reported WHO/UNICEF
96 2015 Survey/reported WHO/UNICEF
97 2014 Survey/reported WHO/UNICEF
99 2013 Survey/reported WHO/UNICEF
96 2012 Survey/reported WHO/UNICEF
99 2011 Survey/reported WHO/UNICEF
99 2010 Survey/reported WHO/UNICEF
99 2009 Survey/reported WHO/UNICEF
99 2008 Survey/reported WHO/UNICEF
99 2007 Survey/reported WHO/UNICEF
99 2006 Survey/reported WHO/UNICEF
96 2005 Survey/reported WHO/UNICEF
99 2004 Survey/reported WHO/UNICEF
99 2003 Survey/reported WHO/UNICEF
99 2002 Survey/reported WHO/UNICEF
94 2001 Survey/reported WHO/UNICEF
99 2000 Survey/reported WHO/UNICEF
95 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
99 2018 Survey/reported WHO/UNICEF
99 2017 Survey/reported WHO/UNICEF
99 2016 Survey/reported WHO/UNICEF
98 2015 Survey/reported WHO/UNICEF
99 2014 Survey/reported WHO/UNICEF
99 2013 Survey/reported WHO/UNICEF
98 2012 Survey/reported WHO/UNICEF
99 2011 Survey/reported WHO/UNICEF
99 2010 Survey/reported WHO/UNICEF
99 2009 Survey/reported WHO/UNICEF
99 2008 Survey/reported WHO/UNICEF
97 2007 Survey/reported WHO/UNICEF
98 2006 Survey/reported WHO/UNICEF
94 2005 Survey/reported WHO/UNICEF
95 2004 Survey/reported WHO/UNICEF
98 2003 Survey/reported WHO/UNICEF
99 2002 Survey/reported WHO/UNICEF
94 2001 Survey/reported WHO/UNICEF
99 2000 Survey/reported WHO/UNICEF
95 1999 Survey/reported WHO/UNICEF
94 1998 Survey/reported WHO/UNICEF
93 1997 Survey/reported WHO/UNICEF
84 1996 Survey/reported WHO/UNICEF
59 1995 Survey/reported WHO/UNICEF
62 1994 Survey/reported WHO/UNICEF
99 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
54 (41 - 80) 2015 Survey/reported Iran National AIDS Committee Secretariat, 2015; Rahnama R et al, 2014
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
42.1 (40.10 - 44.10) 2014 Survey/reported National AIDS Committee Secretariat, 2015.
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
1998
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
% of substance use disorder facilities offering hepatitis treatment
None

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.2 (0.97 - 1.49) 2019 Modelled IHME
1.17 (0.94 - 1.44) 2018 Modelled IHME
1.09 (0.88 - 1.36) 2017 Modelled IHME
0.93 (0.74 - 1.15) 2016 Modelled IHME
0.77 (0.62 - 0.96) 2015 Modelled IHME
0.72 (0.58 - 0.90) 2014 Modelled IHME
0.68 (0.55 - 0.85) 2013 Modelled IHME
0.65 (0.52 - 0.81) 2012 Modelled IHME
0.64 (0.51 - 0.79) 2011 Modelled IHME
0.63 (0.50 - 0.78) 2010 Modelled IHME
0.63 (0.51 - 0.79) 2009 Modelled IHME
0.64 (0.51 - 0.79) 2008 Modelled IHME
0.65 (0.52 - 0.81) 2007 Modelled IHME
0.66 (0.53 - 0.82) 2006 Modelled IHME
0.67 (0.54 - 0.84) 2005 Modelled IHME
0.71 (0.57 - 0.88) 2004 Modelled IHME
0.78 (0.62 - 0.97) 2003 Modelled IHME
0.85 (0.68 - 1.07) 2002 Modelled IHME
0.91 (0.73 - 1.15) 2001 Modelled IHME
0.94 (0.75 - 1.18) 2000 Modelled IHME
0.93 (0.75 - 1.17) 1999 Modelled IHME
0.92 (0.74 - 1.16) 1998 Modelled IHME
0.91 (0.73 - 1.15) 1997 Modelled IHME
0.9 (0.72 - 1.13) 1996 Modelled IHME
0.89 (0.72 - 1.12) 1995 Modelled IHME
0.89 (0.71 - 1.12) 1994 Modelled IHME
0.89 (0.71 - 1.11) 1993 Modelled IHME
0.89 (0.71 - 1.11) 1992 Modelled IHME
0.89 (0.71 - 1.11) 1991 Modelled IHME
0.89 (0.71 - 1.11) 1990 Modelled IHME
0.2 (0.20 - 0.30) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
0.5 (0.20 - 1) 2014 Survey/reported Gower et al, 2014
People who inject drugs (PWID)
Download
Value (%) Year Type Source
44.1 (28.20 - 59.50) 2014 Modelled Degenhardt L et al, 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
519,296 (414,145 - 650,620) 1990 Modelled IHME
523,122 (416,703 - 655,095) 1991 Modelled IHME
522,312 (415,806 - 653,099) 1992 Modelled IHME
528,652 (420,865 - 662,069) 1993 Modelled IHME
539,074 (430,100 - 676,263) 1994 Modelled IHME
549,850 (439,560 - 690,660) 1995 Modelled IHME
563,613 (450,997 - 708,331) 1996 Modelled IHME
581,500 (465,304 - 730,203) 1997 Modelled IHME
601,244 (480,715 - 754,024) 1998 Modelled IHME
619,284 (494,827 - 776,807) 1999 Modelled IHME
631,903 (504,956 - 793,947) 2000 Modelled IHME
623,151 (497,689 - 781,324) 2001 Modelled IHME
590,033 (471,197 - 737,528) 2002 Modelled IHME
546,952 (437,246 - 681,215) 2003 Modelled IHME
506,758 (405,127 - 628,556) 2004 Modelled IHME
485,901 (388,869 - 601,643) 2005 Modelled IHME
481,330 (385,272 - 596,914) 2006 Modelled IHME
478,471 (383,013 - 595,111) 2007 Modelled IHME
477,638 (382,346 - 594,538) 2008 Modelled IHME
478,561 (382,973 - 595,405) 2009 Modelled IHME
481,859 (385,664 - 599,225) 2010 Modelled IHME
491,906 (393,811 - 611,648) 2011 Modelled IHME
512,112 (410,507 - 636,506) 2012 Modelled IHME
541,919 (435,478 - 673,255) 2013 Modelled IHME
580,434 (466,021 - 720,674) 2014 Modelled IHME
627,165 (503,074 - 778,645) 2015 Modelled IHME
758,812 (608,448 - 945,083) 2016 Modelled IHME
903,724 (727,357 - 1,121,660) 2017 Modelled IHME
974,218 (787,506 - 1,204,990) 2018 Modelled IHME
1,012,160 (818,002 - 1,252,200) 2019 Modelled IHME
199,000 (129,000 - 226,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
4.26 (3.72 - 4.90) 2019 Modelled IHME
4.18 (3.67 - 4.78) 2018 Modelled IHME
4.12 (3.64 - 4.69) 2017 Modelled IHME
4.05 (3.59 - 4.61) 2016 Modelled IHME
3.98 (3.55 - 4.52) 2015 Modelled IHME
3.88 (3.45 - 4.38) 2014 Modelled IHME
3.79 (3.38 - 4.26) 2013 Modelled IHME
3.73 (3.32 - 4.17) 2012 Modelled IHME
3.66 (3.27 - 4.08) 2011 Modelled IHME
3.56 (3.19 - 3.96) 2010 Modelled IHME
3.5 (3.16 - 3.92) 2009 Modelled IHME
3.49 (3.13 - 3.87) 2008 Modelled IHME
3.45 (3.10 - 3.85) 2007 Modelled IHME
3.4 (3.05 - 3.81) 2006 Modelled IHME
3.33 (2.98 - 3.75) 2005 Modelled IHME
3.21 (2.87 - 3.61) 2004 Modelled IHME
3.03 (2.70 - 3.44) 2003 Modelled IHME
2.93 (2.61 - 3.33) 2002 Modelled IHME
2.84 (2.50 - 3.22) 2001 Modelled IHME
2.75 (2.40 - 3.15) 2000 Modelled IHME
2.7 (2.30 - 3.10) 1999 Modelled IHME
2.68 (2.28 - 3.13) 1998 Modelled IHME
2.66 (2.24 - 3.08) 1997 Modelled IHME
2.67 (2.27 - 3.11) 1996 Modelled IHME
2.68 (2.23 - 3.11) 1995 Modelled IHME
2.68 (2.21 - 3.13) 1994 Modelled IHME
2.7 (2.26 - 3.15) 1993 Modelled IHME
2.72 (2.27 - 3.21) 1992 Modelled IHME
2.69 (2.23 - 3.18) 1991 Modelled IHME
2.71 (2.24 - 3.24) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
3,595 (3,134 - 4,129) 2019 Modelled IHME
3,490 (3,064 - 3,991) 2018 Modelled IHME
3,403 (3,010 - 3,880) 2017 Modelled IHME
3,312 (2,941 - 3,777) 2016 Modelled IHME
3,223 (2,874 - 3,661) 2015 Modelled IHME
3,110 (2,765 - 3,507) 2014 Modelled IHME
3,004 (2,679 - 3,374) 2013 Modelled IHME
2,923 (2,596 - 3,267) 2012 Modelled IHME
2,833 (2,532 - 3,161) 2011 Modelled IHME
2,723 (2,441 - 3,034) 2010 Modelled IHME
2,655 (2,393 - 2,971) 2009 Modelled IHME
2,614 (2,343 - 2,901) 2008 Modelled IHME
2,546 (2,294 - 2,846) 2007 Modelled IHME
2,483 (2,227 - 2,782) 2006 Modelled IHME
2,399 (2,147 - 2,701) 2005 Modelled IHME
2,289 (2,047 - 2,569) 2004 Modelled IHME
2,128 (1,896 - 2,417) 2003 Modelled IHME
2,024 (1,802 - 2,304) 2002 Modelled IHME
1,934 (1,706 - 2,198) 2001 Modelled IHME
1,848 (1,614 - 2,122) 2000 Modelled IHME
1,792 (1,527 - 2,052) 1999 Modelled IHME
1,744 (1,485 - 2,033) 1998 Modelled IHME
1,696 (1,430 - 1,965) 1997 Modelled IHME
1,672 (1,420 - 1,945) 1996 Modelled IHME
1,649 (1,368 - 1,913) 1995 Modelled IHME
1,620 (1,337 - 1,891) 1994 Modelled IHME
1,601 (1,343 - 1,870) 1993 Modelled IHME
1,596 (1,332 - 1,887) 1992 Modelled IHME
1,588 (1,316 - 1,873) 1991 Modelled IHME
1,584 (1,311 - 1,895) 1990 Modelled IHME
1,267 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
29 (25 - 33) 2019 Modelled IHME
29 (25 - 33) 2018 Modelled IHME
29 (25 - 33) 2017 Modelled IHME
29 (25 - 32) 2016 Modelled IHME
28 (25 - 32) 2015 Modelled IHME
28 (25 - 32) 2014 Modelled IHME
28 (25 - 32) 2013 Modelled IHME
28 (25 - 32) 2012 Modelled IHME
28 (25 - 32) 2011 Modelled IHME
28 (25 - 32) 2010 Modelled IHME
28 (24 - 32) 2009 Modelled IHME
28 (24 - 32) 2008 Modelled IHME
28 (24 - 31) 2007 Modelled IHME
27 (24 - 31) 2006 Modelled IHME
27 (23 - 31) 2005 Modelled IHME
27 (23 - 31) 2004 Modelled IHME
27 (23 - 30) 2003 Modelled IHME
26 (23 - 30) 2002 Modelled IHME
26 (22 - 30) 2001 Modelled IHME
26 (22 - 30) 2000 Modelled IHME
26 (22 - 30) 1999 Modelled IHME
26 (22 - 30) 1998 Modelled IHME
26 (22 - 30) 1997 Modelled IHME
26 (22 - 30) 1996 Modelled IHME
26 (22 - 30) 1995 Modelled IHME
26 (22 - 30) 1994 Modelled IHME
26 (22 - 30) 1993 Modelled IHME
26 (21 - 30) 1992 Modelled IHME
25 (21 - 30) 1991 Modelled IHME
25 (21 - 30) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
54 (41 - 80) 2015 Survey/reported Iran National AIDS Committee Secretariat, 2015; Rahnama R et al, 2014
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
42.1 (40.10 - 44.10) 2014 Survey/reported National AIDS Committee Secretariat, 2015.
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
1998
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
% of substance use disorder facilities offering hepatitis treatment
None

Overview

HBV elimination goal
HCV elimination goal

Hepatitis related deaths (national)

Modelled

HBV
2,471
2019
(2,220 - 2,773)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
3,595
2019
(3,134 - 4,129)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
95 (%)
2019
WHO/UNICEF
Eligible for HBV generic medicines
Eligible for HCV generic medicines